Stay updated on MAPP2 MDMA Therapy Clinical Trial
Sign up to get notified when there's something new on the MAPP2 MDMA Therapy Clinical Trial page.

Latest updates to the MAPP2 MDMA Therapy Clinical Trial page
- CheckyesterdayChange DetectedThe page now displays the ClinicalTrials.gov record for the MAPP2 Phase 3 study of MDMA-assisted psychotherapy for PTSD, including its study design, eligibility criteria, locations, outcomes, and study documents.SummaryDifference58%

- Check8 days agoChange DetectedThe displayed site revision changed from v3.7.2 to v3.8.0 while the page continued to show a 403 error.SummaryDifference0.2%

- Check15 days agoChange DetectedA sitewide NIH notice announces updates and FAQs about replacing the term “Artificial Intelligence” with “Super Intelligence” across NIH content during a transition.SummaryDifference1%

- Check22 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check29 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.0 to v3.7.1, while the page remains a 403 error screen.SummaryDifference0.2%

- Check50 days agoChange DetectedAccess to the study record is blocked by a 403 Forbidden page, replacing the usual study content and documents with a generic error screen.SummaryDifference19%

Stay in the know with updates to MAPP2 MDMA Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MAPP2 MDMA Therapy Clinical Trial page.